Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesia Strategies for Laparoscopic Sleeve Gastrectomy
NCT02662660Phase 3Completed
- Sponsor
- Hospital General Universitario de Elche
- Start
- Jan 2012
- Primary completion
- Dec 2015
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of bupivacaine hydrochloride 0.75% injection and levobupivacaine in postoperative pain (3 arms), sponsored by Hospital General Universitario de Elche. Primary endpoint: Visual Analogic Scale at 24 hours. Started Jan 2012; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injectionlevobupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02662660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02662660.